I'm not sure it progressing "slow" given the R&D expenditure especially in Q3, YF mentioned they plan to gather a lot more data for VAXINIA and OASIS before release compared to what was done for the clinical trial update for VAXINIA so the release of data has been slow but not the progress. And there was a delay for Azer-Cel until Cohort B was dose with combination of IL-2 given they saw Cohort A wasn't going as expected so IMU has now opened multiple recruitment sites in Australia (LC mentioned 5 in the yesterday's Proactive presentation with FPI announced just last month) to catch up the delay. I'm expecting clinical trial updates for VAXINIA and OASIS to be release in 2-5 months as IMU has previously mention then Azer-Cel in 8-11 months with application for Fast Track designation and registrational clinical trial using these data.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)